D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
PP&E Net Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
PP&E Net
myr572m
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
19%
P
PeterLabs Holdings Bhd
KLSE:PLABS
PP&E Net
myr25.1m
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
8%
A
Apex Healthcare Bhd
KLSE:AHEALTH
PP&E Net
myr205.6m
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
7%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
PP&E Net
myr88.6m
CAGR 3-Years
0%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
PP&E Net
myr163.8m
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
4%
K
Kotra Industries Bhd
KLSE:KOTRA
PP&E Net
myr162.2m
CAGR 3-Years
10%
CAGR 5-Years
3%
CAGR 10-Years
0%

See Also

What is Duopharma Biotech Bhd's PP&E Net?
PP&E Net
572m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's PP&E Net amounts to 572m MYR.

What is Duopharma Biotech Bhd's PP&E Net growth rate?
PP&E Net CAGR 10Y
19%

Over the last year, the PP&E Net growth was -1%. The average annual PP&E Net growth rates for Duopharma Biotech Bhd have been 4% over the past three years , 7% over the past five years , and 19% over the past ten years .

Back to Top